GlyTech, Inc.

"GlyTech, Inc. is engaged in the creation of new pharmaceuticals with both domestic and overseas companies, targeting various modalities using its proprietary glycan-related technology. The company supports drug discovery from basic research to API production through three main business segments: contract research, API sales and reagent sales."